Uniqure N.V. (QURE) Stock Price, Quote & News

Company Profile

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial t...

Industry: Biotechnology

Sector: Healthcare

Phone: 31 20 240 6000

Website: www.uniqure.com

Address:

Paasheuvelweg 25, Amsterdam, Netherlands

MF__DOOM Mar. 21 at 7:52 PM

$QQQ $QURE $SPY still holding

0 · Reply

Don_Frye Mar. 20 at 8:05 PM

$QURE i need a few wins , and fast . yeezz

0 · Reply

topstockalerts Mar. 20 at 5:26 PM

$QURE larger cap biotech feel, moves more controlled but can still trend when sentiment shifts.

0 · Reply

ReversalTrack Mar. 20 at 4:32 PM

Something is brewing on ticker JAGU 🚨🚀 One of the most explosive signals is setting up on the daily. Uranium+Rare earth play with news . War changes everything especially energy. ⚛️ Uranium = energy independence + national security Don't sleep on ticker JAGU!! $CODX $ASBP $QURE hot //..1

1 · Reply

verusabiz Mar. 20 at 4:02 PM

$QURE Anyone know anything about why this is moving up? I only have 2,000 shares but looks good

0 · Reply

clarksonhockey Mar. 20 at 3:53 PM

$QURE did news leak? Buyout???? Come to daddy!

1 · Reply

MAGA1717 Mar. 20 at 3:51 PM

$QURE oh yes BB… yippie!

0 · Reply

rooneyray Mar. 20 at 3:32 PM

$QURE Marty Makary buying up shares before he announces his departure from the FDA

1 · Reply

FastRocketTraders Mar. 19 at 6:54 PM

$QURE long here

0 · Reply

topstockalerts Mar. 19 at 5:30 PM

$QURE not a momentum favorite lately but can wake up hard on catalysts. One of those names that goes from dead to active fast.

0 · Reply

QURE SHAREHOLDER NOTICE: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data

Mar 9, 2026, 9:18 AM EDT - 12 days ago

This biotech's stock is soaring after a ‘polarizing' FDA official is stepping down

Mar 5, 2026, 6:01 PM EST - 16 days ago

Federal health officials attacked an Amsterdam-based biotech company seeking approval of a Huntington's disease treatment and accused it of lying

Mar 5, 2026, 2:42 PM EST - 16 days ago

FDA official calls UniQure's gene therapy a 'failed' treatment for Huntington's disease

Mar 5, 2026, 1:11 PM EST - 16 days ago

Sr. FDA official calls Uniqure's Huntington's disease treatment a failure

Mar 5, 2026, 12:11 PM EST - 16 days ago

FDA Defends Call For Placebo Study In uniQure Huntington's Gene Therapy Trial

Mar 4, 2026, 11:01 PM EST - 16 days ago

FDA official says UniQure fell short on Huntington's trial, defends new study request

Mar 3, 2026, 9:34 AM EST - 18 days ago

These Analysts Cut Their Forecasts On uniQure Following Q4 Results

Mar 3, 2026, 8:15 AM EST - 18 days ago

uniQure: The Worst Case Scenario Just Got Official (Rating Downgrade)

Mar 2, 2026, 4:27 PM EST - 19 days ago

uniQure N.V. (QURE) Q4 2025 Earnings Call Transcript

Mar 2, 2026, 7:22 AM EST - 19 days ago

FDA tells UniQure study data insufficient for brain disorder therapy application

Mar 2, 2026, 7:05 AM EST - 19 days ago

uniQure Announces 2025 Financial Results and Provides Recent Company Updates

Feb 27, 2026, 10:49 AM EST - 22 days ago

uniQure: Shares Tumble On Fresh FDA Controversy - What Investors Should Know

Feb 25, 2026, 6:00 PM EST - 24 days ago

QURE INVESTOR REMINDER: uniQure N.V. Investors Have Until April 13, 2026 To Seek Lead Plaintiff Role

Feb 23, 2026, 7:05 AM EST - 26 days ago

uniQure to Announce 2025 Financial Results

Feb 19, 2026, 10:00 AM EST - 4 weeks ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure Lawsuit - QURE

Feb 18, 2026, 10:06 AM EST - 4 weeks ago

UniQure N.V. (QURE) Securities Fraud: Contact Berger Montague To Discuss Your Rights

Feb 17, 2026, 8:16 AM EST - 4 weeks ago

UNIQURE N.V. (QURE) INVESTOR ALERT Investors With Large Losses in uniQure N.V.

Feb 17, 2026, 2:14 AM EST - 4 weeks ago

Diamond Hill International Strategy Q4 2025 Portfolio Review

BABA ICLR NWG

Feb 6, 2026, 1:58 PM EST - 6 weeks ago

Early uniQure Fabry Trial Shows Lasting Enzyme Boost, Safety Watch

Feb 6, 2026, 7:05 AM EST - 6 weeks ago

uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

Jan 29, 2026, 1:22 PM EST - 7 weeks ago

Alger Small Cap Focus Fund Q4 2025 Portfolio Update

EXAS GH NBIS NTRA STVN

Jan 9, 2026, 7:05 AM EST - 2 months ago

uniQure Announces Type A Meeting Scheduled with FDA

Jan 8, 2026, 3:36 PM EST - 2 months ago

uniQure: Now What?

Dec 16, 2025, 12:17 PM EST - 3 months ago

What's Going On With uniQure Stock On Tuesday?

Dec 7, 2025, 12:01 PM EST - 3 months ago

Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years

Dec 4, 2025, 1:30 PM EST - 3 months ago

Why uniQure Stock Is Trading Lower After FDA Meeting Update

Dec 4, 2025, 7:05 AM EST - 3 months ago

uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease

Nov 17, 2025, 8:59 AM EST - 4 months ago

Diamond Hill International Strategy Q3 2025 Performance Review

BABA HDB TSM

Nov 14, 2025, 4:17 AM EST - 4 months ago

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE

Nov 12, 2025, 10:00 AM EST - 4 months ago

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm

Nov 10, 2025, 12:44 PM EST - 4 months ago

From Setback To Surge: UniQure's Huntington's Hope Is Poised For Upside

Nov 10, 2025, 11:11 AM EST - 4 months ago

uniQure N.V. (QURE) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 7:05 AM EST - 4 months ago

uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 6, 2025, 7:05 AM EST - 4 months ago

uniQure to Announce Third Quarter 2025 Financial Results

MF__DOOM Mar. 21 at 7:52 PM

$QQQ $QURE $SPY still holding

0 · Reply

Don_Frye Mar. 20 at 8:05 PM

$QURE i need a few wins , and fast . yeezz

0 · Reply

topstockalerts Mar. 20 at 5:26 PM

$QURE larger cap biotech feel, moves more controlled but can still trend when sentiment shifts.

0 · Reply

ReversalTrack Mar. 20 at 4:32 PM

1 · Reply

verusabiz Mar. 20 at 4:02 PM

$QURE Anyone know anything about why this is moving up? I only have 2,000 shares but looks good

0 · Reply

clarksonhockey Mar. 20 at 3:53 PM

$QURE did news leak? Buyout???? Come to daddy!

1 · Reply

MAGA1717 Mar. 20 at 3:51 PM

$QURE oh yes BB… yippie!

0 · Reply

rooneyray Mar. 20 at 3:32 PM

$QURE Marty Makary buying up shares before he announces his departure from the FDA

1 · Reply

FastRocketTraders Mar. 19 at 6:54 PM

$QURE long here

0 · Reply

topstockalerts Mar. 19 at 5:30 PM

$QURE not a momentum favorite lately but can wake up hard on catalysts. One of those names that goes from dead to active fast.

0 · Reply

cupcakes4jesus Mar. 19 at 2:53 PM

$QURE apparently Makary is getting fired today or tomorrow. Ive heard from many sources

3 · Reply

SuperGreenToday Mar. 18 at 11:11 PM

$QURE Share Price: $14.73 Contract Selected: Oct 16, 2026 $15 Calls Buy Zone: $4.50 – $5.57 Target Zone: $8.51 – $10.40 Potential Upside: 78% ROI Time to Expiration: 211 Days | Updates via https://fxcapta.com/stockinfo/

1 · Reply

calidave123 Mar. 18 at 1:05 PM

$QURE https://www.biospace.com/fda/what-the-leucovorin-approval-signals-or-doesnt-about-the-fdas-rare-disease-stance

0 · Reply

stu4 Mar. 18 at 1:48 AM

$QURE because of the CEO MATT !!! Said it all along Ex stock broker , not a CEO

0 · Reply

FastRocketTraders Mar. 17 at 11:58 PM

$QURE

0 · Reply

Peterson28 Mar. 17 at 7:40 PM

$QURE Who the dumb bought the massive $30 calls expiring this Friday?

0 · Reply

janed102 Mar. 17 at 5:45 PM

$QURE company would be worth more if it delisted from the US stock market

0 · Reply

pk81 Mar. 17 at 2:08 PM

$QURE

0 · Reply

verusabiz Mar. 16 at 7:36 PM

$QURE what a pos this has turned out to be, no one wants to own it

0 · Reply

calidave123 Mar. 16 at 9:18 AM

$QURE

0 · Reply

Th3M4skedSt0nker Mar. 16 at 3:01 AM

$KYTX is an easy 100%-200% this year alone. Might happen actually very fast within next 3 months with the given catalyst pipeline. Strong institutional ownership. Strong insider confidence with recent market buys. Only retail is still sleeping on this beauty...compare no. of watchers to $SLS $CING $QURE Good Luck Dear Ladies and Gentlemen 💲 💲💲

1 · Reply

MichaelReis Mar. 15 at 10:38 PM

$QURE

0 · Reply

Market Cap	921.05M
Revenue (ttm)	16.10M
Net Income (ttm)	-198.97M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,235.84%
Debt to Equity Ratio	0.25

Volume	5,757,900
Avg Vol	3,740,182
Day's Range	N/A - N/A
Shares Out	62.53M
Stochastic %K	38%
Beta	0.73
Analysts	Strong Sell
Price Target	$38.55